Mesenchymal Stem Cells for Polycystic Ovary Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.
Who Is on the Research Team?
Chadwick C Prodromos, MD
Principal Investigator
The Foundation for Orthopaedics and Regenerative Medicine
Are You a Good Fit for This Trial?
This trial is for people diagnosed with polycystic ovary syndrome (PCOS) confirmed by ultrasound. Other specific exclusions are not listed.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells
Trial Overview
The study is testing the safety and effectiveness of giving mesenchymal stem cells, taken from donated umbilical cords or placentas, through an IV to treat PCOS.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Intravenous infusion
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Foundation for Orthopaedics and Regenerative Medicine
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.